5 articles
Toronto, Ontario – TheNewswire - October 22 , 2026 – NeuroThera Labs Inc. (TSXV: NTLX) (the " Company " or " NeuroThera "), a clinical-stage pharmaceutical company and a subsidiary…
INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that it has entered into a Master Services Agreement with Uniphar Durbin…
Cette nouvelle activité vise à soutenir la croissance des revenus, à élargir l'offre commerciale et à développer la clientèle de la Société au Québec et dans d'autres régions canadiennes. Varennes,…
Vancouver, October 19, 2026 - TheNewswire – Mr. Jerzy Wilczewski announces the disposition of 800,000 common shares (“ Common Shares ”) in the capital of Helix Biopharma Corp. (“ Helix…
